Abstract
The voltage-gated calcium channel is composed of a pore-forming α1 subunit and several regulatory subunits: α2δ, β, and γ. We report here the identification of a novel α2δ subunit, α2δ-4, from the expressed sequence tag database followed by its cloning and characterization. The novel α2δ-4 subunit gene contains 39 exons spanning about 130 kilobases and is co-localized with theCHCNA1C gene (α1C subunit) on human chromosome 12p13.3. Alternative splicing of the α2δ-4 gene gives rise to four potential variants, a through d. The open reading frame of human α2δ-4a is composed of 3363 base pairs encoding a protein with 1120 residues and a calculated molecular mass of 126 kDa. The α2δ-4a subunit shares 30, 32, and 61% identity with the human calcium channel α2δ-1, α2δ-2, and α2δ-3 subunits, respectively. Primary sequence comparison suggests that α2δ-4 lacks the gabapentin binding motifs characterized for α2δ-1 and α2δ-2; this was confirmed by a [3H]gabapentin-binding assay. In human embryonic kidney 293 cells, the α2δ-4 subunit associated with CaV1.2 and β3 subunits and significantly increased CaV1.2/β3-mediated Ca2+influx. Immunohistochemical study revealed that the α2δ-4 subunit has limited distribution in special cell types of the pituitary, adrenal gland, colon, and fetal liver. Whether the α2δ-4 subunit plays a distinct physiological role in select endocrine tissues remains to be demonstrated.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|